
    
      The study will be carried out in collaboration with the Kaiser Permanente Medical Care
      Program (KPMCP) under the direction of the Kaiser Permanente Vaccine Study Center (KPVSC).
      KPMCP is a closed-panel healthcare organization that maintains comprehensive encounter
      databases that capture all medical care received by enrollees.

      Vaccination will be according to routine clinical practice. Vaccination databases will be
      reviewed to identify eligible persons receiving Menactra vaccine within the KPMCP system.
    
  